• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼氟酸在人体中的药代动力学及生物利用度。

The pharmacokinetics and availability of niflumic acid in humans.

作者信息

Houin G, Tremblay D, Bree F, Dufour A, Ledudal P, Tillement J P

出版信息

Int J Clin Pharmacol Ther Toxicol. 1983 Mar;21(3):130-4.

PMID:6852999
Abstract

The pharmacokinetic parameters and relative availability of niflumic acid in two different pharmaceutical preparations were studied in 12 subjects after a single oral administration. Total plasma clearance averaged 45 ml/min, and the half-life of elimination approximately 2 h, giving a distribution volume of 0.12 l/kg on the average. The values of these pharmacokinetic parameters were in agreement with the general characteristics of this type of substance, a weak acid strongly bound to plasma proteins. Comparison of the systemic availability of the two oral forms showed no difference; they were probably close to 100%.

摘要

在12名受试者单次口服给药后,研究了两种不同药物制剂中尼氟酸的药代动力学参数和相对生物利用度。血浆总清除率平均为45 ml/min,消除半衰期约为2小时,平均分布容积为0.12 l/kg。这些药代动力学参数值与这类物质(一种与血浆蛋白紧密结合的弱酸)的一般特征相符。两种口服剂型的全身生物利用度比较显示无差异;它们可能接近100%。

相似文献

1
The pharmacokinetics and availability of niflumic acid in humans.尼氟酸在人体中的药代动力学及生物利用度。
Int J Clin Pharmacol Ther Toxicol. 1983 Mar;21(3):130-4.
2
[Determination of the concentrations of niflumic acid in the plasma and synovial tissue following repeated administration of capsules].
Rev Rhum Mal Osteoartic. 1987 Apr;54(4):339-41.
3
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.曲马多的药代动力学及肠内曲马多制剂的生物利用度。第二次通讯:含乙醇滴剂
Arzneimittelforschung. 1998 May;48(5):436-45.
4
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.三种剂型单次静脉注射和口服氯普噻吨后的药代动力学
Arzneimittelforschung. 1996 Mar;46(3):247-50.
5
Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
Clin Pharmacol Ther. 1995 Nov;58(5):506-11. doi: 10.1016/0009-9236(95)90170-1.
6
Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers.氟康唑栓剂在健康志愿者中的药代动力学及耐受性
Arzneimittelforschung. 1993 Mar;43(3):391-5.
7
Pharmacokinetics of benzydamine.苄达明的药代动力学。
Int J Tissue React. 1985;7(3):195-204.
8
Pharmacokinetics of flufenamic acid in man.
Int J Clin Pharmacol Ther Toxicol. 1987 Apr;25(4):185-7.
9
Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.人体中非甾体抗炎药尼氟灭酸的检测:一项19F磁共振波谱体内与体外联合研究
NMR Biomed. 2003 May;16(3):144-51. doi: 10.1002/nbm.820.
10
Pharmacokinetics of amiodarone after intravenous and oral administration.胺碘酮静脉注射和口服后的药代动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Nov;20(11):524-9.

引用本文的文献

1
YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy.基于YAP/TAZ抑制剂的药物递送系统用于选择性肿瘤蓄积和癌症联合治疗。
Biomacromolecules. 2025 Jan 13;26(1):266-278. doi: 10.1021/acs.biomac.4c01076. Epub 2024 Dec 7.
2
An activator of voltage-gated K channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1.电压门控 K 通道 Kv1.1 的激活剂作为 1 型发作性共济失调的治疗候选物。
Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2207978120. doi: 10.1073/pnas.2207978120. Epub 2023 Jul 24.
3
Comparative study between direct analysis in whole blood, oral fluid, and declaration of consumption for the prevalence of nonsteroidal anti-inflammatory drugs and acetaminophen in ultratrail runners.
全血、唾液与自我申报检测法在评估超长距离跑者中常用非甾体抗炎药与对乙酰氨基酚使用情况的对比研究。
Drug Test Anal. 2023 Jan;15(1):97-103. doi: 10.1002/dta.3374. Epub 2022 Oct 2.
4
Characterization of the interaction between fenamates and hippocampal neuron GABA(A) receptors.非甾体抗炎芬那酸类药物与海马神经元γ-氨基丁酸A(GABA(A))受体相互作用的特性研究
Neurochem Int. 2007 Nov-Dec;51(6-7):440-6. doi: 10.1016/j.neuint.2007.04.017. Epub 2007 May 3.
5
Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.鉴定人肝脏中负责氟尼辛葡糖醛酸化的人尿苷二磷酸葡萄糖醛酸基转移酶。
Pharm Res. 2006 Jul;23(7):1502-8. doi: 10.1007/s11095-006-0250-5. Epub 2006 Jun 21.